SEEL logo

Seelos Therapeutics (SEEL) Current Liabilities

Annual Current Liabilities

$38.93 M
+$13.77 M+54.73%

December 31, 2023

Summary

Performance

1-Year Change

+54.73%

3-Year Change

+424%

5-Year Change

+3221.5%

15-Year Change

+2359.13%

SEEL Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$38.93 M
SEEL annual total current liabilities is currently at an all-time high

3-Year Low

$8.29 M
SEEL annual total current liabilities is currently +369.75% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SEEL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
SEEL next annual earnings announcement has not yet been scheduled

OtherSEELbalance sheetmetrics:

Annual Total Liabilities

$38.93 M
SEEL annual total liabilities is $38.93 million

Annual Total Long Term Liabilities

$0.00
SEEL annual total long term liabilities is $0.00

Annual Total Assets

$5.42 M
SEEL annual total assets is $5.42 million

Annual Current Assets

$5.40 M
SEEL annual total current assets is $5.40 million

Quarterly Current Liabilities

$30.51 M
-$6.20 M-16.89%

June 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

+471.42%

SEEL Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$56.11 M
SEEL quarterly total current liabilities is currently -45.62% below its historical high of $56.11 million

3-Year Low

$8.29 M
SEEL quarterly total current liabilities is currently +268.22% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
SEEL previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
SEEL next earnings announcement has not yet been scheduled

OtherSEELbalance sheetmetrics:

Quarterly Total Liabilities

$30.51 M
SEEL quarterly total liabilities is $30.51 million

Quarterly Long Term Liabilities

$0.00
SEEL quarterly total long term liabilities is $0.00

Quarterly Total Assets

$2.38 M
SEEL quarterly total assets is $2.38 million

Quarterly Current Assets

$2.33 M
SEEL quarterly total current assets is $2.33 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$38.93 M
SEEL annual total current liabilities is $38.93 million

Annual Accounts Payable

$16.40 M
SEEL annual accounts payable is $16.40 million

Annual Short Term Debt

$14.23 M
SEEL annual short term debt is $14.23 million

SEEL Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+54.7%0.0%
3 y3 years+424.0%0.0%
5 y5 years+3221.5%+471.4%

SEEL Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-78.7%-45.6%-72.8%
5 y5-yearat high-80.9%-45.6%-90.7%
alltimeall timeat high-98.2%-45.6%-99.0%

Seelos Therapeutics Current Liabilities History

DateAnnualQuarterly
Jun 2024
-
$30.51 M(-16.9%)
Mar 2024
-
$36.72 M(-5.7%)
Dec 2023
$38.93 M(+54.7%)
$38.93 M(+10.2%)
Sep 2023
-
$35.33 M(-37.0%)
Jun 2023
-
$56.11 M(+43.1%)
Mar 2023
-
$39.20 M(+55.8%)
Dec 2022
$25.16 M(+203.6%)
$25.16 M(+14.9%)
Sep 2022
-
$21.89 M(+49.6%)
Jun 2022
-
$14.63 M(+44.4%)
Mar 2022
-
$10.13 M(+22.2%)
Dec 2021
$8.29 M(+11.5%)
$8.29 M(+3.1%)
Sep 2021
-
$8.03 M(+5.8%)
Jun 2021
-
$7.59 M(-43.1%)
Mar 2021
-
$13.34 M(+79.5%)
Dec 2020
$7.43 M(-31.1%)
$7.43 M(+161.7%)
Sep 2020
-
$2.84 M(-23.4%)
Jun 2020
-
$3.71 M(-48.6%)
Mar 2020
-
$7.21 M(-33.1%)
Dec 2019
$10.78 M(+819.6%)
$10.78 M(+94.6%)
Sep 2019
-
$5.54 M(+3.7%)
Jun 2019
-
$5.34 M(-42.6%)
Mar 2019
-
$9.31 M(+694.1%)
Dec 2018
$1.17 M(-26.0%)
$1.17 M(-17.8%)
Sep 2018
-
$1.43 M(-25.1%)
Jun 2018
-
$1.90 M(+12.6%)
Mar 2018
-
$1.69 M(+6.8%)
Dec 2017
$1.58 M(-86.0%)
$1.58 M(-12.7%)
Sep 2017
-
$1.81 M(-1.6%)
Jun 2017
-
$1.84 M(-28.8%)
Mar 2017
-
$2.59 M(-77.1%)
Dec 2016
$11.29 M(-28.0%)
$11.29 M(-10.4%)
Sep 2016
-
$12.61 M(-5.0%)
Jun 2016
-
$13.27 M(+0.1%)
Mar 2016
-
$13.25 M(-15.5%)
Dec 2015
$15.68 M(+127.1%)
$15.68 M(+128.8%)
Sep 2015
-
$6.86 M(+37.8%)
Jun 2015
-
$4.97 M(-30.5%)
Mar 2015
-
$7.16 M(+3.6%)
Dec 2014
$6.91 M(-41.3%)
$6.91 M(+8.1%)
Sep 2014
-
$6.39 M(-8.4%)
Jun 2014
-
$6.97 M(-52.2%)
Mar 2014
-
$14.58 M(+24.0%)
Dec 2013
$11.76 M(+9.2%)
$11.76 M(+40.0%)
Sep 2013
-
$8.40 M(-23.7%)
Jun 2013
-
$11.00 M(+8.2%)
Mar 2013
-
$10.17 M(-5.5%)
Dec 2012
$10.77 M(+7.4%)
$10.77 M(-27.2%)
Sep 2012
-
$14.78 M(+35.9%)
Jun 2012
-
$10.87 M(+9.9%)
Mar 2012
-
$9.89 M(-1.3%)
DateAnnualQuarterly
Dec 2011
$10.02 M(+332.6%)
$10.02 M(+247.0%)
Sep 2011
-
$2.89 M(-21.5%)
Jun 2011
-
$3.68 M(+44.9%)
Mar 2011
-
$2.54 M(+9.6%)
Dec 2010
$2.32 M(-83.7%)
$2.32 M(+24.0%)
Sep 2010
-
$1.87 M(-20.7%)
Jun 2010
-
$2.35 M(-80.4%)
Mar 2010
-
$12.01 M(-15.3%)
Dec 2009
$14.17 M(+912.6%)
$14.17 M(+3026.4%)
Sep 2009
-
$453.40 K(-55.5%)
Jun 2009
-
$1.02 M(+6.0%)
Mar 2009
-
$962.50 K(-31.2%)
Dec 2008
$1.40 M(-39.9%)
$1.40 M(-44.2%)
Sep 2008
-
$2.51 M(+22.6%)
Jun 2008
-
$2.05 M(-11.8%)
Mar 2008
-
$2.32 M(-0.3%)
Dec 2007
$2.33 M(-68.4%)
$2.33 M(-35.8%)
Sep 2007
-
$3.63 M(-2.1%)
Jun 2007
-
$3.71 M(-48.5%)
Mar 2007
-
$7.19 M(-2.4%)
Dec 2006
$7.37 M(-6.7%)
$7.37 M(-16.4%)
Sep 2006
-
$8.82 M(-1.1%)
Jun 2006
-
$8.92 M(+31.8%)
Mar 2006
-
$6.77 M(-14.3%)
Dec 2005
$7.90 M(+281.8%)
$7.90 M(+46.1%)
Sep 2005
-
$5.41 M(+186.7%)
Jun 2005
-
$1.89 M(+2.0%)
Mar 2005
-
$1.85 M(-10.7%)
Dec 2004
$2.07 M(-32.7%)
$2.07 M(-14.4%)
Sep 2004
-
$2.42 M(-31.0%)
Jun 2004
-
$3.50 M(+11.8%)
Mar 2004
-
$3.13 M(+1.8%)
Dec 2003
$3.07 M(-43.9%)
$3.07 M(+58.3%)
Sep 2003
-
$1.94 M(-27.8%)
Jun 2003
-
$2.69 M(-50.3%)
Mar 2003
-
$5.41 M(-1.4%)
Dec 2002
$5.48 M(+120.9%)
$5.48 M(+198.4%)
Sep 2002
-
$1.84 M(-24.5%)
Jun 2002
-
$2.43 M(+20.2%)
Mar 2002
-
$2.03 M(-18.4%)
Dec 2001
$2.48 M(+99.3%)
$2.48 M(+82.5%)
Sep 2001
-
$1.36 M(+23.1%)
Jun 2001
-
$1.11 M(-14.1%)
Mar 2001
-
$1.29 M(+3.3%)
Dec 2000
$1.25 M(+77.9%)
$1.25 M(+159.7%)
Sep 2000
-
$479.60 K(+50.7%)
Jun 2000
-
$318.20 K(-24.7%)
Mar 2000
-
$422.80 K
Dec 1999
$700.00 K(-78.5%)
-
Dec 1997
$3.26 M
-

FAQ

  • What is Seelos Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Seelos Therapeutics?
  • What is Seelos Therapeutics annual current liabilities year-on-year change?
  • What is Seelos Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Seelos Therapeutics?
  • What is Seelos Therapeutics quarterly current liabilities year-on-year change?

What is Seelos Therapeutics annual total current liabilities?

The current annual current liabilities of SEEL is $38.93 M

What is the all time high annual current liabilities for Seelos Therapeutics?

Seelos Therapeutics all-time high annual total current liabilities is $38.93 M

What is Seelos Therapeutics annual current liabilities year-on-year change?

Over the past year, SEEL annual total current liabilities has changed by +$13.77 M (+54.73%)

What is Seelos Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of SEEL is $30.51 M

What is the all time high quarterly current liabilities for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly total current liabilities is $56.11 M

What is Seelos Therapeutics quarterly current liabilities year-on-year change?

Over the past year, SEEL quarterly total current liabilities has changed by $0.00 (0.00%)